drugset / Trial / NCT07192549

Perioperative GDNF as a Predictive Factor for Postoperative Delirium and Adverse Neurological Outcomes in Pediatric Surgery

NCT07192549

Not yet recruiting 200 enrolled General Hospital of Ningxia Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

To observe the dynamic changes in serum levels of inflammatory cytokines (e.g., IL-6, TNF-α), Brain-Derived Neurotrophic Factor (BDNF), and Glial Cell Line-Derived Neurotrophic Factor (GDNF) during the perioperative period in pediatric patients undergoing Scheduled Laparoscopic Hernia Repair surgery, and to investigate their relationship with the occurrence of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD),and to compare the different influence between propofol and sevoflurane . The aim is to provide insights into the neurobiological mechanisms underlying these complications and to identify potential biomarkers for risk stratification.

Timeline

Start
2025-09-15
Primary completion
2030-09-01
Completion
2030-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 0.5 mg/kg Intravenous
Subject Sevoflurane Other / unclassified 1 % Inhaled
Subject Sevoflurane Other / unclassified 3 % Inhaled
Background Remifentanil Small molecule Intravenous
Background Remimazolam Small molecule Intravenous
Background Rocuronium Other / unclassified Intravenous
Background Sufentanil Other / unclassified Intravenous

Indications